The UHC2030 Private-Sector Constituency (UHC2030 PSC) is the convening platform for private sector entities wishing to exchange and collaborate on universal health coverage.

The constituency has two representatives serving on the UHC2030 Steering Committee. In 2021, the constituency’s nominated representatives are Edward Booty of Reach52 and Ruchika Singhal of Medtronic. A third representative, Olesya Struck of Philips, serves as an alternate.  

The private sector constituency convenes virtually on a monthly basis and is hosted by the World Bank Group.


Composition

The constituency currently has over 40 members representing different fields of activity, notionally in the following categories: health services; disruptive technology; medical technology; pharmaceuticals; supply chain; and industry associations. 

UHC2030 works with private sector entities that directly provide services and goods within the health value chain, such as service providers, health insurers, and manufacturers and distributors of medicines and health products as well as innovative and disruptive technologies with applications to the health market.

When private sector entities join the UHC2030 Private Sector Constituency, they make a commitment to contribute to UHC and write a statement about what they are doing to contribute to UHC - See the full list of members and their individual statements.

Accessible Quality Health Services, South Africa

“We developed a very cost-effective membership model that ensures that people with low salaries are prepared for primary health care emergencies. Our clinics leverage task shifting, efficient processes and innovative technologies to make health care services more affordable, effective while maintaining quality and safety measures.”

AMREF Enterprises Limited, Kenya

"Amref Enterprises Limited (AEL) is the social enterprise arm of Amref Health Africa that is responsible for delivering sustainable social value through incubation and commercialization of innovative solutions conceptualized and developed throughout the organization. Amref Health Africa has embraced social entrepreneurship as a mechanism that combines the efficiency of the entrepreneurial private sector with the welfare orientation of the public sector. AEL has positioned itself to strengthen the primary health care system as part of an important ingredient for the achievement of Universal Health Coverage (UHC) in Africa. AEL contributed to UHC through developing, incubating and accelerating innovative mobile technology solutions for training, health financing and data collection. AEL also increases access to quality, affordable health services and products through public private partnership like community pharmacies and points of care and improving public health facilities." 

Apollo Hospitals Enterprise Ltd, India

“At Apollo we recognized the urgency to invest in public health almost four decades ago, and are now looking at strengthening our engagement with like-minded institutions working towards strengthening the collective mission of Universal Health Coverage (UHC) as part of achieving sustainable development goals (SDGs). Apollo has dedicated 5% of its Tier 2 hospital beds for free treatment of the underprivileged population under several state health insurance schemes. Through Apollo’s Total Health Programme we are providing integrated health care to over 70,000 population under our CSR. Apollo's NCDs Mission through innovations such as mobile clinic program, digital health solutions, has screened more than 6 million people under its NCDs Get Active initiative. Apollo Remote and Tele-Healthcare is complementing cost effective quality healthcare solutions in rural, suburban and semi urban areas as well as remote locations in Himalayas. We have done 1.6 million tele-consultations.”

Astra Zeneca

AstraZeneca supports universal health coverage outcomes of financial protection and access to quality health services for all.  We are working towards a future where everyone can access sustainable healthcare solutions aimed at life-changing treatments and prevention. Our mission is to push the boundaries of science to deliver life-changing medicines. We support investments in health systems around the world to ensure that our medicines are available to people who need them. We address affordability issues to enable access to our medicines Through screenings and awareness programmes and training healthcare professionals, we seek to support access to disease prevention and treatment.

BD Global Health

To strengthen health care systems in the developing world, BD Global Health makes critical technologies available on an affordable basis. These products - including diagnostic tools and medical devices - improve the rational use of medicine and delivery of healthcare in resource-limited settings. We leverage BD talent and capabilities to help strengthen health systems and improve clinical practices, in partnership with leading public sector organizations. We collaborate with organizations to develop and launch innovations to address unmet needs in areas such as TB, HIV, maternal newborn health, cancer and antimicrobial resistance.

Common Health

Common Health is a purpose-driven business that uses digital and mobile technology to advance universal health coverage. Half the world’s population lacks access to essential health services, more than a billion people have risk factors for non-communicable diseases, and 800 million families face financial catastrophe due to the cost of medical care. Common Health addresses these challenges through four integrated platforms: health insurance and payments, primary health care, health engagement, and provider networks. Each of these components leverages mobile phone infrastructure – now reaching five billion people around the globe – to transform health care delivery, change behaviours, and drive long-term impact. Incorporated in the United States with a hub in Kuala Lumpur, Common Health works to make quality health care more accessible for people across low- and middle-income countries, beginning in South Asia and Southeast Asia.

Dimagi, USA

Dimagi aims to improve health outcomes through providing mobile technology to frontline health workers to further enable training, support, and supervision of health programs in low-income environments. We have completed over 2,000 diverse health technology projects in over 80 countries with over 100 partners, focusing most recently on simplifying the use of technology by an invaluable partner in care – the community health workers.

We seek to unlock the tremendous potential of CHW programs with CommCare, our innovative, open-source mHealth solution for CHWs that tracks and supports every client. In order for a new technology solution to be successful, we recognized that it must be able to bridge the dimensions of being an innovative, disruptive technology, lead to a high rate adoption, and demonstrate high impact through proven research.

Fullerton Healthcare Corporation Limited, Singapore

“Fullerton Health supports Universal Health Coverage (UHC) across the Asia Pacific region by delivering affordable and accessible care through our healthcare facilities. We have a strong focus on primary care and population health management in the healthcare value chain, as we believe a robust primary care sector is the foundation for healthcare accessibility. We invest in health systems strengthening through building capacity and capability across the APAC region. We also collaborate with public and private organisations to deliver the societal and commercial benefits of integrated care to patients.”

GE Medical Systems, France

“GE Healthcare’s Primary & Referral Care – Africa initiative designs and implements integrated primary healthcare delivery models comprised of appropriate technologies; training and capacity building of healthcare workers, including task shifting; and regular monitoring & evaluation to improve access to quality and affordable care where access to quality healthcare is limited or non-existent.

Through the initiative, communities in the remotest parts of Africa now have access to healthcare services that enable early detection and timely management of maternal and newborn health complications, non-communicable diseases, and safe surgery, in some cases for the first time.

To-date, along with partners, we have 19 programs in 7 countries, over 150,000 expectant women, and newborns have been directly impacted, and over 1,500 healthcare workers, including midwives and nurses have been trained.

We will continue working with all relevant stakeholders to implement at scale, evidence-based PHC programs to inform contextualized benefits package designs continent-wide.”

German Health Alliance, Germany

"The GHA – German Health Alliance supports its member entities to be successful and to contribute to health system strengthening and global health with top quality health solutions in the international context. Our membership consists of entities from different actor groups in health and is multi-sectoral. Many of these companies, NGOs and academia are engaging in projects to strengthen the UHC, as optimising the outcomes, such as financial protection, affordability and accessibility of essential health (services) without discrimination.Therefore, the work of the GHA aims to strengthen the German healthcare sector with regards to the international competition. We advocate for the improvement of framework conditions, better chances of market entry and positioning German entities as partners for efficient, adequate and sustainable healthcare solutions. Our statement for a stronger political commitment to achieve UHC is directed towards the German national and international politicians."

GlaxoSmithKline, UK

"We believe the private sector can play a significant role in achieving UHC. To this end, GSK stands ready to work with all stakeholders to ensure a sustainable and equitable approach to achieving UHC. GSK is committed to supporting the realisation of the SDG target to achieve UHC globally by 2030 through our business activities of making our medicines, vaccines and consumer healthcare products available. We also contribute through our partnerships focused on capacity building and health systems strengthening. Specifically, GSK published a set of 13 commitments describing the actions we will take to help deliver societal value and build trust. In this way, GSK stands ready to work with all stakeholders to ensure a sustainable and equitable approach to achieving UHC."

Global Diagnostic Imaging, Healthcare IT & Radiation Therapy Trade Association, Belgium

"DITTA supports the improvement of quality of care by continuously innovating medical technologies to provide products and services which are safer, more effective and affordable. Moreover, to ensure that all medical electronical equipment provided at global level is of high quality, safe and effective, DITTA contributes to international standards. This being especially important in countries which do not have regulatory frameworks for medical devices. To ensure the financial protection of people in need of healthcare, our company works with several financial institutions to enable the private sector to provide the right technologies to governments and respond to their specific demands. Also, to improve the access to affordable technologies and avoid possible corruption, DITTA is working on new financing models."

Global Self Care Federation, Switzerland

“The Global Self-Care Federation advocates for increased practice of responsible self-care as a means of easing the burden of overstretched health systems, demonstrating long term savings for governments and healthcare systems across the world, enabling a better use of resources, helping to achieve UHC. The practice of responsible self-care can recognise the strengths of individuals as active agents of their own health, and not merely passive recipients of health services. Rational use of self-care is essential in moving the healthcare system from disease management to prevention, by encouraging individuals to adopt preventative measures and interventions.”

Healthcare Federation of Nigeria

The HFN reiterates her commitment to ensuring continuous support for the development of models that can help to prevent catastrophic levels of health spending as a result of seeking for quality healthcare. For instance, this can be done by bringing on board the relevant stakeholders to develop and implement financial protection models/frameworks through the institution of policies on demand side financing; the Institution of Healthcare Insurance as an intervention for beneficiaries who are unable to access healthcare. 

Actions to quality health care services and safe, effective, quality and affordable medicines and health products for all: 

  • Advocating and developing plans for the creation of the enabling environment to provide quality healthcare
  • Developing initiatives on supply side financing from the perspective of all stakeholders, lessors and lessees; issues such as interest rates, the need for dedicated equipment and health care products leasing funds, etc.
  • The development of the initiatives and a framework around demand side financing 
  • advocating for the establishment of an effective referral system and enabling access to care
  • exploring innovative and disruptive public/private partnerships

HealthSetGo, India

"Healthsetgo is India's pioneering school health organization, nurturing a healthy, disease free future for India by inculcating healthy habits from a young age at schools and providing access to preventive healthcare. Driven by the vision of 'Every Child Healthy' - we provide access to quality, affordable healthcare to urban and below poverty line families in the school environment in India. Our programs involve conducting annual preventive medical health checkups at schools on various parameters through a team of doctors to identify early stage health risks in children from 2-17 years. Till date we have detected 300,000 unseen conditions that were directly affecting the quality of life for children and using our proprietary health technology, have mapped them to recommendations and nearest treatment centers. By providing these data driven medical reports, we have empowered parents, schools and governments to make timely interventions. We would be happy to share learnings, best practice with the constituency, if and when required, as well as be present at various forums for discussions to present a youth point of view which is required for UHC. Conversely, we would be happy to implement other global best practices for UHC across our beneficiaries in India. We are constantly working with the Indian Government and regulatory ecosystem to drive UHC in policy and in implementation." 

Henry Schein, USA

“Henry Schein aims to positively impact health around the world by aligning our strengths as a business with the needs of society.  The idea of "doing well by doing good" is exemplified by our corporate social responsibility program, Henry Schein Cares.  As a business we engage our five constituents in a "Higher Ambition" model of building deep trust-based relationships driven by a sense of purpose and accountability.  As a corporate citizen, we utilize these relationships to improve sustainability and expand access to health care. Through numerous partnerships and health care product donations to non-governmental organizations, health care professional associations, health care professionals and community-based programs focused on prevention, wellness, and treatment; disaster preparedness and relief; and capacity building of health institutions that provide training and care, Henry Schein helps increase access to care in communities around the world.”

International Federation of Pharmaceutical Manufacturers and Associations, Switzerland

“Our contributions to health systems strengthening, improving primary care and enhancing health workforce capacity all are significant elements to supporting better access to quality healthcare services and treatments, and in turn, universal health coverage.”

Japan Pharmaceutical Manufacturers Association, Japan

"Pharmaceutical companies of JPMA are contributing to the achievement of the UHC through capacity building in developing countries and regions. For example, where shortage of doctors and nurses, poor infrastructure, and lack of disease awareness are the major barriers to access to medicines, the industry has responded by training health workers, introducing mobile medical services, running disease awareness programs etc."

Johnson & Johnson, Belgium

“We are firmly committed to doing our part, in partnership with others, to ensure the promise of UHC becomes a reality for patients, families and communities around the world. Doing so requires a mix of global and country-specific programs as well as policy-shaping work. Around the world we support more than hundreds of health-related programs and we strive through these to align with government priorities, advocating with both local and central government for quality healthcare workers, especially for women and children.”

Kenya Association of Pharmaceutical Industry, Kenya

“40-70% of healthcare expenditure in Kenya goes to pharmaceuticals. The implication of this is that for the consumer to be shielded from unaffordable healthcare the cost of pharmaceuticals has to be controlled. PSK is on track to control the prices and offload the burden from the patient by having a standardized model of practice that reduces unnecessary costs in the medicine supply chain. This model of practice, branded Greencross, aggregates supply, cuts down the number of duplicate products and ensures adequately trained personnel in each member pharmacy. This guarantees the quality of both the product and the service.”

Mamotest

Mamotest has developed a system to exponentially increase access to health care while reducing time and costs. Mamotest installs state-of-the-art mammographs and operates to improve access for women living in remote areas. It is estimated that each Mamotest centre saves 1 Millon dollars to the public health sector. By supporting the installation and operation of mammographs in remote areas and investing in health care workforce trainings to provide timely and quality results, Mamotest enables early diagnosis of breast cancer and reduces treatment costs.

Medtronic Labs, USA

"Formalized in 2016, Medtronic Labs is a distinct social business that maximizes social impact alongside financial sustainability. Medtronic Labs designs healthcare delivery service models with and for underserved communities that integrate digital and product technologies across the patient care continuum. To amplify our impact and reach scale, we partner with local tech entrepreneurs, healthcare providers, NGOs, governments, and other stakeholders. Our programs are focused on providing high quality and effective care through technology-enabled service delivery models. To find out more about our specific programs, please click on the links: Our commercial programs currently include Shruti and Empower Health. Within our innovative pipeline we have two programs, Prema and Maisha Mapya. Through the current programs, global partnerships, and pilot projects, Medtronic Labs has expanded access for over half a million people throughout South Asia and Africa - and our work is just beginning."

MEDx EHealthcenter, Netherlands

“MEDx strongly believes that the healthcare system is not made up of isolated groups but, instead, of interdependent entities – healthcare seekers, their relatives, national and international healthcare providers and public institutions – which work together to achieve greater outcomes for both the care seeker and the care providers. To facilitate the interdependent relationships and interactions within communities; we have developed a Digital Hospital. An end-to-end or one-stop-shop for all care services focusing on self-care management and primary, secondary and tertiary cares. This new model stimulates all parties involved to achieve Nationwide UHC deployment though technology by:

• Building trust 

• Cooperating

• Taking responsibilities

• Thinking beyond own interests and long-term

• Continuously improving

• Increasing the healthcare standards.”

Merck, USA

"As a global health care company that is committed to improving health and well-being around the world, SDG 3 (Good Health and Well-Being) is a core of our business and is aligned with our mission to save and improve lives. We [also] recognize that barriers to quality care and medical treatment - such as lack of trained health care professionals, weak infrastructure, political uncertaintly, civil strife, and a shortage of safe water in many parts of the world - make even basic health care delivery difficult at best. These challenges go well beyond what we can directly address alone, so we work in partnership with a range of stakeholders to improve the global health ecosystem."

mHealth Global, Canada

1. We are developing innovative public-private financing mechanisms that prevent catastrophic health expenses for individuals and provide access to group-based primary and secondary preventive health services. 

2. We have developed and continue to refine telehealth software and hardware solutions that couple longitudinal behaviour change programs with a telehealth screening, diagnosis, consultation and management platform. 

Mission & Co., Malaysia

“Through the ‘Health In Your Hands' initiative, our main focus is on addressing healthcare, health promotion and prevention for those at the ‘last mile’ - meaning neglected people (marginalised groups for e.g. refugees and mental health patients), neglected places (meaning remote locations or those with no access to health services and infrastructure) and neglected (health) problems (where traditional public health national expenditures are not fully allocated such as essential surgery, mental health etc).”

Novartis, Switzerland

"Novartis Social Business (NSB) is an example of a business unit that supports global public health through novel sustainable business models. Our activities are rooted in local communities, where we work with partners to provide affordable, high-quality medicines against infectious and chronic diseases while strengthening healthcare capacity." 

Novo Nordisk, Denmark

“Through our Access to Insulin Commitment Novo Nordisk offers low-cost insulin to 78 least developed and low- and middle-income countries, as well as to selected humanitarian organisations. Knowing that it takes more than medicine to manage diabetes we are furthermore partnering to build capacity and strengthen healthcare systems through a number of programmes and support provided by the World Diabetes Foundation.”

Organization of Pharmaceutical Producers of India, India

“OPPI advocates for mobilizing resources equitably and efficiently to ensure everyone can get the heath care they need without fear of financial hardship. Also, OPPI has continuously demonstrated social and economic benefits of UHC for a diverse country like India and is devoted to building higher political commitment for the same.”

Ottobock, Germany

"The value of mobility devices reaches far beyond medical health. Helping people with disabilities to restore mobility and protect the mobility they have retained enables them to participate actively in economic and social life. Therefore, Ottobock is working with cross- and multisectoral stakeholders to include mobility devices and related services into UHC, thus making them accessible and affordable for all.”

Pfizer, USA

“Pfizer believes in the promise of UHC.  We recognize that access to safe, effective, quality and affordable medicines and vaccines is a critical component of UHC[i] and that, as an innovative pharmaceutical company, we have an important role to play in helping to deliver on this target. We therefore commit to helping to accelerate equitable and sustainable progress towards UHC by tackling affordability and access head on – Pfizer is committed to addressing patient affordability and access globally.  As part of a series of bold moves, we have challenged ourselves to dramatically increase the number of patients that have access to our medicines by 2023.  To do this, we are exploring new business models such as linking reimbursement to the performance of our medicines and paying for specialty medicines over time. We are also involved in several pilots looking at more significant changes to pricing and reimbursement models.  We are committed to working closely with stakeholders and governments to accelerate these changes and improve overall access.”

Pharmaceutical Society of Kenya, Kenya

"Pharmaceutical Society of Kenya (PSK) recognizes that pharmacists are strategically placed as primary caregivers since most healthcare seekers contact the pharmacy as the first point of contact with the health system. Involved in the entire medicines value chain from manufacture, to supply chain, to dispensing, pharmacists are a valuable resource in medicines access, a core component in health provision. Therefore, PSK represents pharmacists and strengthens their professional expertise and commitment to constantly update their knowledge and skills. Moreover, PSK developed standards to ensure that patients are provided with high quality pharmaceutical products and care country-wide. Thereby, contributing to universal health coverage by improving the safety of drugs and quality of care by pharmacists to the people,"

Praava Health

Praava Health is changing the way health care is delivered in Bangladesh with a “brick and click” model – quality brick and mortar services, powered by technology. We’re shifting culture away from hospital-centric, transactional, and episodic care to value-based outpatient care focused on prevention. Our doctors spend 15 minutes with patients, educating them about disease prevention and wellness. This enables more personal and empathetic patient-doctor relationships, creating a continuity of care, improving outcomes for patients, and reducing burdens on the health system overall.

reach52

“Our technology and community-owned service model enables rural healthcare access to essential services and products. To improve access to quality health services, we build offline-first apps for low-spec devices that allow us to train members of the community to be ‘Access Managers’, filling the gaps where traditional health infrastructure doesn't reach through our health outreach campaigns, local supports and connections to a range of public and private services. Moreover, we collect data upfront on healthcare needs to allow us to work with cross-sector stakeholders to get products and services people need, targeting key health issues at a village-by-village level. We actively partner with government health workers and have built an app for health worker education, improving their skills and service delivery quality. To improve the financial protection of people, we deliver health support in local communities through our apps and Access Managers (avoiding cost of travel) and work with the private sector to distribute discounted products, lowering out-of-pocket expenses.”

Royal Philips, Netherlands

“At Philips, we believe every person on this planet should have access to high-quality, affordable care. Digital health solutions have to become a vital part of UHC to strengthen health systems and achieve health coverage especially for the many, not the few. With our innovations, we connect people, data and technology to optimize care delivery. Digital and technological innovation on its own will not be enough to achieve UHC by 2030. It will require responsible leadership, a collaborative approach, new business models and financing solutions within a strong legal framework.”

Sanofi Aventis Group, France

“Because one-third of the world’s population does not have access to quality healthcare solutions, we are committed to exploring ways to ensure people get the treatments they need and improving their quality of life." “Improving access to healthcare requires tackling various barriers. It means innovating to address unmet medical needs and develop new solutions to bring healthcare to patients, ensuring that the conditions are in place in terms of production, supply chain and market access, to make the products and treatments available to people. It also means building capacity and awareness for stronger healthcare systems. Finally, improving the affordability of products, treatments and related services is also crucial.”

Sumitomo Chemical Company, Japan

"Within the framework of the Sustainable Development Goals, Sumitomo Chemical has articulated a clear, ongoing commitment to continuously innovate new tools for malaria until eradication is ultimately achieved. While our activity is deeply focused around a leadership role in eradicating malaria, Sumitomo Chemical believes that UHC is the foundation for achieving all health goals. As a Japanese company, we see 2019 as a critical year to engage with the UHC2030 platform, given Japan’s leading role on the G20, TICAD meeting and leadership in planning the High-Level Meeting on UHC. Sumitomo Chemical commits to continuously develop innovative health tools to protect from vector-borne disease and will work with countries and multi-lateral partners around the world to facilitate access to health tools for all."

Swoop Aero

Swoop Aero's  founders had a vision of making basic health care such as vaccinations accessible for everyone, everywhere. They saw the inadequacies in the existing health care supply chain, particularly in rural and remote areas with poor infrastructure and accessibility challenges, and set out to transform last-mile health care deliveries. By removing the reliance on road-based transport models and shifting them to the air, the reach, speed and flexibility of health care provision can be drastically improved. Health care providers have access to an on-demand delivery service, meaning they always have access to the essential supplies when and where they’re needed and can spend more time doing what they do best: caring for their communities. There are so many existing and potential use cases but all share two key benefits: improved patient outcomes and access to affordable basic health care.

Takeda Pharmaceutical Company, Japan

Takeda supports SDG goal 3.8 including the principle of financial risk protection. As a biopharmaceutical company, we intend to provide access to our innovative medicines for as many patients as possible through Takeda's access to medicine initiatives including assistance programs that make medicines more affordable for patients in a sustainable way. We are also developing programs that ‘go beyond medicines’ to help educate patients about diseases and treatments, improve the diagnostic rates for non-infectious diseases, help provide transport to medical facilities, and provide medical education to health workers.

Taleam Systems

Taleam Systems has been working in the computer and technology field since 2011, and we are now better positioned to expand our business in the areas of developing health products such as hearing aids, and accommodating handicapped people by attaching tablets directly to their wheelchairs. We believe that our innovations would leave no one behind.

Download: Private sector statements on UHC

You are currently offline. Some pages or content may fail to load.